DOCSLIB.ORG

Tumor-Infiltrating Regulatory T Cells Inhibit Endogenous

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Tumor-Infiltrating Regulatory T Cells Inhibit Endogenous The Journal of Immunology Tumor-Infiltrating Regulatory T Cells Inhibit Endogenous Cytotoxic T Cell Responses to Lung Adenocarcinoma ,† ,1 ‡, Anusha-Preethi Ganesan,* Magnus Johansson,* Brian Ruffell,* Adam Beltran, x , ,‡,1 Jonathan Lau,* David M. Jablons,* x and Lisa M. Coussens* Downloaded from Immune cells comprise a substantial proportion of the tumor mass in human nonsmall cell lung cancers (NSCLC), but the precise composition and significance of this infiltration are unclear. In this study, we examined immune complexity of human NSCLC as well as NSCLC developing in CC10-TAg transgenic mice, and revealed that CD4+ T lymphocytes represent the dominant population of + + + CD45 immune cells, and, relative to normal lung tissue, CD4 Foxp3 regulatory T cells (Tregs) were significantly increased as + + a proportion of total CD4 cells. To assess the functional significance of increased Tregs, we evaluated CD8 T cell–deficient/CC10- TAg mice and revealed that CD8+ T cells significantly controlled tumor growth with antitumor activity that was partially repressed http://www.jimmunol.org/ by Tregs. However, whereas treatment with anti-CD25–depleting mAb as monotherapy preferentially depleted Tregs and improved CD8+ T cell–mediated control of tumor progression during early tumor development, similar monotherapy was ineffective at later stages. Because mice bearing early NSCLC treated with anti-CD25 mAb exhibited increased tumor cell death associated with infiltration by CD8+ T cells expressing elevated levels of granzyme A, granzyme B, perforin, and IFN-g, we therefore evaluated carboplatin combination therapy resulting in a significantly extended survival beyond that observed with chemotherapy alone, indicating that Treg depletion in combination with cytotoxic therapy may be beneficial as a treatment strategy for advanced NSCLC. The Journal of Immunology, 2013, 191: 2009–2017. at Univ of California-San Diego Serials/Biomed Lib 0699 on August 23, 2013 ung cancer is the most common cause of cancer-related (8–12). As Tregs are thought to function primarily in cancer by + mortality worldwide, with ∼85% being of the nonsmall repressing CD8 T cell functionality, the reciprocal relationship L cell lung cancer (NSCLC) histological subtype, and as- between these two immune cell subtypes indicates that depleting sociated with prior tobacco use (1). Despite advances in treat- Tregs might be therapeutically beneficial. ment modalities, survival rates for advanced lung cancer re- Indeed, several studies employing carcinogen-induced or trans- main poor; thus, innovative therapeutic approaches are urgently plantable tumor models have reported therapeutic efficacy by de- needed. pleting Tregs based upon increased expression of IL-2R/CD25 (13). Retrospective analysis of most human tumors (2), including lung However, tumors arise spontaneously following an initiating (3–7), has revealed a significant correlation between immune in- mutation and not by sudden introduction of fully transformed filtration by CD8+ cytotoxic T cells and improved outcome. In cells, or by high-dose, short-period carcinogen exposure. Fur- contrast, infiltration of tumors by regulatory T cells (Tregs) ex- thermore, therapeutic efficacy in these studies was only observed pressing the lineage-specific transcription factor FOXP3 is instead when depletion was performed prior to tumor cell inoculation or associated with poor prognosis in NSCLC and other carcinomas cancer initiation, making translation of these findings to the clinic difficult. As the tumor immune microenvironment and the immunosup- *Department of Pathology, University of California, San Francisco, San Francisco, pressive cell types that function in tissues are distinct, we first CA 94143; †Cancer Sciences Division, University of Southampton, Southampton SO16 6YD, United Kingdom; ‡Helen Diller Family Comprehensive Cancer Center, evaluated leukocyte complexity of human NSCLC and found + University of California, San Francisco, San Francisco, CA 94143; and xDepartment that CD4 T cells were significantly increased relative to adjacent of Surgery, University of California, San Francisco, San Francisco, CA 94143 + + normal lung tissue, and that CD4 FOXP3 Tregs constituted a sig- 1 Current address: Department of Cell and Developmental Biology, Knight Cancer nificant proportion of these tumor-infiltrating cells. To determine Institute, Oregon Health and Science University, Portland, OR. the functional significance of these adaptive leukocytes, and the Received for publication May 17, 2013. Accepted for publication June 14, 2013. cellular and molecular mediators of pro- versus antitumor im- This work was supported by Cancer Research UK (to A.-P.G.); the Department of munity, we used a transgenic mouse model of multistage lung Defense Breast Cancer Research Program (to B.R.); National Institutes of Health/ National Cancer Institute Grants R01 CA130980, R01 CA140943, R01 CA155331, carcinogenesis, namely CC10-TAg mice, in which SV40 T Ag- and U54 CA163123; Department of Defense Breast Cancer Research Program Era of driven carcinogenesis mirrors that of aggressive human lung Hope Scholar Expansion Award BC10412; Susan G. Komen Foundation Grants + KG111084 and KG110560; the Breast Cancer Research Foundation (to L.M.C.); cancers (14). We revealed that, whereas CD8 Tlymphocytes and National Institutes of Health/National Cancer Institute Grant R01 CA132566 are critical in restraining lung tumor growth, their recruitment (to D.M.J. and L.M.C.). into tumors and bioeffector functions are inhibited by CD4+ Address correspondence and reprint requests to Dr. Lisa M. Coussens at the current + Foxp3 Tregs, depletion of which significantly prolongs survival address: Cell and Developmental Biology, Knight Cancer Institute, Oregon Health and Science University, Mail Code L215, 3181 SW Sam Jackson Park Road, Port- of tumor-bearing mice in combination with chemotherapy (CTX). land, OR 97239-3098. E-mail address: [email protected] The online version of this article contains supplemental material. Materials and Methods Abbreviations used in this article: CTX, chemotherapy; DC, dendritic cell; NSCLC, Human tissue samples nonsmall cell lung cancer; Treg, regulatory T cell. Patients with NSCLC who had not received neoadjuvant therapy were Copyright Ó 2013 by The American Association of Immunologists, Inc. 0022-1767/13/$16.00 recruited into the study under approval of local Institutional Review Boards. www.jimmunol.org/cgi/doi/10.4049/jimmunol.1301317 2010 Tregs INHIBIT CYTOTOXIC RESPONSES IN LUNG ADENOCARCINOMA Informed written consent was obtained from the patients. Tumor tissue, (eBioscience). All samples were analyzed on a LSRII flow cytometer adjacent normal tissue, and blood were collected from patients following (BD Biosciences). surgical resection at University of California, and histopathological diag- nosis was obtained at the same center. Quantitative PCR assays mRNA was obtained by processing tissue samples as per recommendations Animal studies using RNeasy Micro/Mini Kit (Qiagen) and quantified with NanoDrop ND- Generation of CC10-TAg mice and characterization of their neoplastic/ 1000 (Thermo Fisher Scientific). cDNA was prepared from mRNA by histopathological stages have been previously reported (15). CC10-TAg reverse transcription using Superscript III. Preamplification of cDNA for mice deficient in B cells (JH2/2), CD4+ T cells (CD42/2), CD8+ T cells genes of interest was performed using TaqMan PreAmp Master Mix Kit (CD82/2), and both CD4+ and CD8+ T cells (CD4+/2CD8+/2) were gen- (Applied Biosystems). PCR amplification to 40 cycles was performed using erated by backcrossing JH+/2, CD4+/2, CD8+/2, and CD4+/2CD8+/2 mice, TaqMan gene expression assays (Applied Biosystems) for respective genes respectively, into the FvB/n strain to at least N5 (16, 17), followed by and TaqMan gene expression master mix (Applied Biosystems) in 20 ml intercrossing with CC10-TAg mice. All animal studies and procedures reactions at recommended cycle temperature conditions on an ABI 7900HT Downloaded from conformed to National Institutes of Health guidelines and were approved quantitative PCR machine (ABI Biosystems). Differences in gene expression by University of California Institutional Animal Care and Use Committee. were determined by calculating relative expression as fold change over TBP For in vivo depletion studies, mice were injected i.p. with 400 mg anti- used as the housekeeping gene. CD25 mAb (clone PC61) and 500 mg anti-CD8 mAb (clone YTS169.4) every 5 d for the respective time periods, as indicated. For survival studies, Statistical analyses mice were treated with 400 mg anti-CD25 mAb (clone PC61) or isotype Statistical analyses were performed using Prism 4.0 (GraphPad Software). control from 8 wk of age until end stage defined by 15% weight loss. Differences between groups for all parameters were determined using http://www.jimmunol.org/ Carboplatin (Hospira) was injected i.p. at 50 mg/kg every 5 d for three Mann–Whitney U test (unpaired, nonparametric, two tailed), except for doses starting at 13 wk of age. survival studies in which log rank test was used. *p , 0.05, **p , 0.01, ***p , 0.001 are shown for all figures. Histology and tumor size Mice were sacrificed at indicated time points, and all tissues were collected Results following intracardiac PBS perfusion. Tissues were fixed in 10% neutral- Human NSCLC are infiltrated by CD4+ T and B lymphocytes buffered formalin or frozen in OCT. Tumor burden of each mouse was quantified in five H&E-stained serial sections (100
Load more

Recommended publications
  • Antibody-Dependent Cellular Cytotoxicity Riiia and Mediate Γ
    Effector Memory αβ T Lymphocytes Can Express Fc γRIIIa and Mediate Antibody-Dependent Cellular Cytotoxicity This information is current as Béatrice Clémenceau, Régine Vivien, Mathilde Berthomé, of September 27, 2021. Nelly Robillard, Richard Garand, Géraldine Gallot, Solène Vollant and Henri Vié J Immunol 2008; 180:5327-5334; ; doi: 10.4049/jimmunol.180.8.5327 http://www.jimmunol.org/content/180/8/5327 Downloaded from References This article cites 43 articles, 21 of which you can access for free at: http://www.jimmunol.org/content/180/8/5327.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Effector Memory ␣␤ T Lymphocytes Can Express Fc␥RIIIa and Mediate Antibody-Dependent Cellular Cytotoxicity1 Be´atrice Cle´menceau,*† Re´gine Vivien,*† Mathilde Berthome´,*† Nelly Robillard,‡ Richard Garand,‡ Ge´raldine Gallot,*† Sole`ne Vollant,*† and Henri Vie´2*† Human memory T cells are comprised of distinct populations with different homing potential and effector functions: central memory T cells that mount recall responses to Ags in secondary lymphoid organs, and effector memory T cells that confer immediate protection in peripheral tissues.
    [Show full text]
  • A Novel CD4+ CTL Subtype Characterized by Chemotaxis and Inflammation Is Involved in the Pathogenesis of Graves’ Orbitopa
    Cellular & Molecular Immunology www.nature.com/cmi ARTICLE OPEN A novel CD4+ CTL subtype characterized by chemotaxis and inflammation is involved in the pathogenesis of Graves’ orbitopathy Yue Wang1,2,3,4, Ziyi Chen 1, Tingjie Wang1,2, Hui Guo1, Yufeng Liu2,3,5, Ningxin Dang3, Shiqian Hu1, Liping Wu1, Chengsheng Zhang4,6,KaiYe2,3,7 and Bingyin Shi1 Graves’ orbitopathy (GO), the most severe manifestation of Graves’ hyperthyroidism (GH), is an autoimmune-mediated inflammatory disorder, and treatments often exhibit a low efficacy. CD4+ T cells have been reported to play vital roles in GO progression. To explore the pathogenic CD4+ T cell types that drive GO progression, we applied single-cell RNA sequencing (scRNA-Seq), T cell receptor sequencing (TCR-Seq), flow cytometry, immunofluorescence and mixed lymphocyte reaction (MLR) assays to evaluate CD4+ T cells from GO and GH patients. scRNA-Seq revealed the novel GO-specific cell type CD4+ cytotoxic T lymphocytes (CTLs), which are characterized by chemotactic and inflammatory features. The clonal expansion of this CD4+ CTL population, as demonstrated by TCR-Seq, along with their strong cytotoxic response to autoantigens, localization in orbital sites, and potential relationship with disease relapse provide strong evidence for the pathogenic roles of GZMB and IFN-γ-secreting CD4+ CTLs in GO. Therefore, cytotoxic pathways may become potential therapeutic targets for GO. 1234567890();,: Keywords: Graves’ orbitopathy; single-cell RNA sequencing; CD4+ cytotoxic T lymphocytes Cellular & Molecular Immunology
    [Show full text]
  • Understanding the Immune System: How It Works
    Understanding the Immune System How It Works U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Allergy and Infectious Diseases National Cancer Institute Understanding the Immune System How It Works U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Allergy and Infectious Diseases National Cancer Institute NIH Publication No. 03-5423 September 2003 www.niaid.nih.gov www.nci.nih.gov Contents 1 Introduction 2 Self and Nonself 3 The Structure of the Immune System 7 Immune Cells and Their Products 19 Mounting an Immune Response 24 Immunity: Natural and Acquired 28 Disorders of the Immune System 34 Immunology and Transplants 36 Immunity and Cancer 39 The Immune System and the Nervous System 40 Frontiers in Immunology 45 Summary 47 Glossary Introduction he immune system is a network of Tcells, tissues*, and organs that work together to defend the body against attacks by “foreign” invaders. These are primarily microbes (germs)—tiny, infection-causing Bacteria: organisms such as bacteria, viruses, streptococci parasites, and fungi. Because the human body provides an ideal environment for many microbes, they try to break in. It is the immune system’s job to keep them out or, failing that, to seek out and destroy them. Virus: When the immune system hits the wrong herpes virus target or is crippled, however, it can unleash a torrent of diseases, including allergy, arthritis, or AIDS. The immune system is amazingly complex. It can recognize and remember millions of Parasite: different enemies, and it can produce schistosome secretions and cells to match up with and wipe out each one of them.
    [Show full text]
  • Late Stages of T Cell Maturation in the Thymus
    ARTICLES Late stages of T cell maturation in the thymus involve NF-B and tonic type I interferon signaling Yan Xing, Xiaodan Wang, Stephen C Jameson & Kristin A Hogquist Positive selection occurs in the thymic cortex, but critical maturation events occur later in the medulla. Here we defined the precise stage at which T cells acquired competence to proliferate and emigrate. Transcriptome analysis of late gene changes suggested roles for the transcription factor NF-B and interferon signaling. Mice lacking the inhibitor of NF-B (IB) kinase (IKK) kinase TAK1 underwent normal positive selection but exhibited a specific block in functional maturation. NF-B signaling provided protection from death mediated by the cytokine TNF and was required for proliferation and emigration. The interferon signature was independent of NF-B; however, thymocytes deficient in the interferon- (IFN-) receptor IFN-R showed reduced expression of the transcription factor STAT1 and phenotypic abnormality but were able to proliferate. Thus, both NF-B and tonic interferon signals are involved in the final maturation of thymocytes into naive T cells. T cell development occurs in the thymus, which provides a unique reside predominantly in the medulla; however, not all SP thymocytes microenvironment and presents ligands consisting of self peptide and are equivalent. major histocompatibility complex (MHC) molecules to T cell anti- CD24hiQa2lo SP thymocytes have been defined as ‘semi-mature’ gen receptors (TCRs). In the cortex of the thymus, low-affinity TCR and have been shown to be susceptible to apoptosis when triggered interactions initiate positive selection signals in CD4+CD8+ double- through the TCR6.
    [Show full text]
  • CD29 Identifies IFN-Γ–Producing Human CD8+ T Cells with an Increased Cytotoxic Potential
    + CD29 identifies IFN-γ–producing human CD8 T cells with an increased cytotoxic potential Benoît P. Nicoleta,b, Aurélie Guislaina,b, Floris P. J. van Alphenc, Raquel Gomez-Eerlandd, Ton N. M. Schumacherd, Maartje van den Biggelaarc,e, and Monika C. Wolkersa,b,1 aDepartment of Hematopoiesis, Sanquin Research, 1066 CX Amsterdam, The Netherlands; bLandsteiner Laboratory, Oncode Institute, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands; cDepartment of Research Facilities, Sanquin Research, 1066 CX Amsterdam, The Netherlands; dDivision of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; and eDepartment of Molecular and Cellular Haemostasis, Sanquin Research, 1066 CX Amsterdam, The Netherlands Edited by Anjana Rao, La Jolla Institute for Allergy and Immunology, La Jolla, CA, and approved February 12, 2020 (received for review August 12, 2019) Cytotoxic CD8+ T cells can effectively kill target cells by producing therefore developed a protocol that allowed for efficient iso- cytokines, chemokines, and granzymes. Expression of these effector lation of RNA and protein from fluorescence-activated cell molecules is however highly divergent, and tools that identify and sorting (FACS)-sorted fixed T cells after intracellular cytokine + preselect CD8 T cells with a cytotoxic expression profile are lacking. staining. With this top-down approach, we performed an un- + Human CD8 T cells can be divided into IFN-γ– and IL-2–producing biased RNA-sequencing (RNA-seq) and mass spectrometry cells. Unbiased transcriptomics and proteomics analysis on cytokine- γ– – + + (MS) analyses on IFN- and IL-2 producing primary human producing fixed CD8 T cells revealed that IL-2 cells produce helper + + + CD8 Tcells.
    [Show full text]
  • Download Helper and Cytotoxic T Cells.Pdf
    Category: Cells Helper and Cytotoxic T cells Original author: Tracy Hussell, University of Manchester, UK UpdatedMelissa Bedard, by: Hannah MRC Jeffery,Human Immunology University of Unit, Birmingham University of Oxford T cells are so called because they are predominantly produced in the thymus. They recognise foreign particles (antigen) by a surface expressed, highly variable, T cell receptor (TCR). There are two major types of T cells: the helper T cell and the cytotoxic T cell. As the names suggest helper T cells ‘help’ other cells of the immune system, whilst cytotoxic T cells kill virally infected cells and tumours. Unlike antibody, the TCR cannot bind antigen directly. Instead it needs to have broken-down peptides of the antigen ‘presented’ to it by an antigen presenting cell (APC). The molecules on the APC that present the antigen are called major histocompatibility complexes (MHC). There are two types of MHC: MHC class I and MHC class II. MHC class I presents to cytotoxic T cells; MHC class II presents to helper T cells. The binding of the TCR to the MHC molecule containing the antigen peptide is a little unstable and so co-receptors are required. The CD4 co-receptor (left image, below) is expressed by helper T cells and the CD8 co-receptor (right image, below) by cytotoxic T cells. Although most T cells express either CD4 or CD8, some express both and proportion do not express either (“double negative” (DN)). Most T cells are defined as CD4 or CD8 but some are classified into additional types such as invariant Natural Killer T cells (iNKT), and Mucosal Associated Invariant T cells (MAIT) The TCR is made up of multiple chains to assist the transmission of the signal to the T cell.
    [Show full text]
  • Cross-Tissue Immune Cell Analysis Reveals Tissue-Specific Adaptations and Clonal Architecture 2 Across the Human Body
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.28.441762; this version posted April 28, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Cross-tissue immune cell analysis reveals tissue-specific adaptations and clonal architecture 2 across the human body 3 Authors: 4 Domínguez Conde C1, *, Gomes T 1,*, Jarvis LB2, *, Xu C 1,*, Howlett SK 2, Rainbow DB 2, Suchanek O3 , 5 King HW 4, Mamanova L 1, Polanski K 1, Huang N1 , Fasouli E 1, Mahbubani KT 5, Prete M 1, Campos L 1,6, 6 Mousa HS 2, Needham EJ 2, Pritchard S 1,, Li T 1,, Elmentaite R 1,, Park J 1,, Menon DK 7, Bayraktar OA 1, 7 James LK 4, Meyer KB 1,, Clatworthy MR 1,3, Saeb-Parsy K 5,#, Jones JL 2, #, Teichmann SA 1,8, # 8 Affiliations: 9 1. Wellcome Sanger Institute, Cambridge, UK 10 2. Department of Clinical Neurosciences, University of Cambridge 11 3. Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK 12 4. Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK 13 5. Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research 14 Centre, Cambridge, UK 15 6. West Suffolk Hospital NHS Trust, Bury Saint Edmunds, UK 16 7. Department of Anaesthesia, University of Cambridge, Cambridge, UK 17 8. Theory of Condensed Matter, Cavendish Laboratory, Department of Physics, University of 18 Cambridge, Cambridge, UK 19 *Co-first authors 20 #Corresponding authors 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.04.28.441762; this version posted April 28, 2021.
    [Show full text]
  • Peptide-Induced Positive Selection of TCR Transgenic Thymocytes in a Coreceptor-Independent Manner
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Immunity, Vol. 6, 643±653, May, 1997, Copyright 1997 by Cell Press Peptide-Induced Positive Selection of TCR Transgenic Thymocytes in a Coreceptor-Independent Manner Eric Sebzda,* Mabel Choi,* Wai Ping Fung-Leung,² of the TCR and coreceptor to an MHC molecule conveys Tak W. Mak,*³ and Pamela S. Ohashi* lck to other kinases associated with the TCR complex, *Ontario Cancer Institute ultimately leading to downstream signaling. However, Departments of Medical Biophysics TCR transgenic mice expressing mutant CD8 molecules and Immunology that are unable to associate with lck are still able to Toronto, Ontario M5G 2M9 undergo thymocyte selection (Chan et al., 1993), sug- Canada gesting that CD8±lck interactions are not essential for ² R. W. Johnson Pharmaceutical T cell maturation. Similar results were obtained using Research Institute mutant CD4 molecules (Killeen and Littman, 1993). Addi- 3535 General Atomics Ct. tional experiments using TCR transgenic mice lacking San Diego, California 92121 the CD8a cytoplasmic domain have shown a defect in ³ Amgen Institute MHC class I±restricted positive selection, suggesting 620 University Ave. that an intracellular portion of CD8a is involved in thymo- Toronto, Ontario M5G 2C1 cyte development (Fung-Leung et al., 1993). Recent Canada work has also implicated the CD8b chain in signaling during T cell maturation (Crooks and Littman, 1994; Fung-Leung et al., 1994; Itano et al., 1994a; Nakayama Summary et al., 1994). Therefore, the exact function of CD8 during thymocyte selection remains unresolved. In addition to T cell receptor (TCR) transgenic thymocytes specific a potential role in signaling, experiments have demon- for the LCMV gp peptide are normally positively se- strated that coreceptors contribute to thymocyte± lected to the CD8 lineage.
    [Show full text]
  • T Cells by Regulatory T Cells + CD8 Differential Suppression of Tumor
    Differential Suppression of Tumor-Specific CD8 + T Cells by Regulatory T Cells Edward James, Alex Yeh, Cathy King, Firouzeh Korangy, Ian Bailey, Denise S. Boulanger, Benoît J. Van den Eynde, This information is current as Nicholas Murray and Tim J. Elliott of October 2, 2021. J Immunol 2010; 185:5048-5055; Prepublished online 4 October 2010; doi: 10.4049/jimmunol.1000134 http://www.jimmunol.org/content/185/9/5048 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2010/10/04/jimmunol.100013 Material 4.DC1 References This article cites 42 articles, 19 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/185/9/5048.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 2, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2010 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Differential Suppression of Tumor-Specific CD8+ T Cells by Regulatory T Cells Edward James,* Alex Yeh,*,1 Cathy King,* Firouzeh Korangy,† Ian Bailey,* Denise S.
    [Show full text]
  • Specific Cytotoxic T Cells Eliminate Cells Producing Neutralizing
    LETTERS TO NATURE Specific cytotoxic T cells a eliminate cells producing neutralizing antibodies 0 oi Oliver Planz, Peter Seiler, Hans Hengartner g b & Rolf M. Zinkernagel E ai Institute for Experimental Immunology, Department of Pathology, C. University of Zurich, Schmelzbergstrasse 12, CH-8091 Zurich, Switzerland :;::;i "'2 IN medically important infections with cytopathic viruses, neu­ > tralizing antibodies are generated within 6-14 days. In contrast, such protective antibodies appear late (50-150 days) after infec­ tion with immunodeficiency virus (HIV) and hepatitis B virus (HBV) in humans, or lymphocytic choriomeningitis virus 2 (LCMV) in mice1-6. However, during these infections, non­ <1.7-ce.--r---+---+-,i,-c'-"9--+------+-- neutralizing antibodies appear much earlier2·6•7• It has been o 5 101520 40 60 80 proposed that T cells suppress antibody responses generally Time (days) and against viruses in vitro 6·S-10• Here we show that the suppres­ sion of neutralizing-antibody responses in LCMV infections in FIG. 1 Kinetics of neutralizing and non-neutralizing antibody responses to mice is due to selective infection of neutralizing-antibody­ LCMV. a, BALB/c mice were infected i.v. with 102 PFU of LCMV-WE. Virus producing B cells by this non-cytopathic virus, and their sub­ titre ( •) in the blood of these mice is usually not detectable. Nucleoprotein­ sequent destruction by virus-specific cytotoxic T cells. Such specitic antibodies (A) appear between days 6 and 8 after infection and stay specific B-cell elimination that leads to a delay in neutralizing­ at a constant level during the whole observation period; the cross in antibody production could help to establish persistent virus parentheses indicates that only 20% of BALB/c mice infected with infections by non-cytopathic viruses.
    [Show full text]
  • CD8 T Cell Differentiation During Immune Responses Sara Sofia De Campos Pereira Lemos
    CD8 T cell differentiation during immune responses Sara Sofia de Campos Pereira Lemos To cite this version: Sara Sofia de Campos Pereira Lemos. CD8 T cell differentiation during immune responses. Immunol- ogy. Université René Descartes - Paris V, 2014. English. NNT : 2014PA05T009. tel-01059806 HAL Id: tel-01059806 https://tel.archives-ouvertes.fr/tel-01059806 Submitted on 2 Sep 2014 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITÉ PARIS DESCARTES FACULTÉ DE MEDECINE-site Necker INSERM U1020 (ex U591) _______________________________________________________________________ THÈSE Pour obtenir le grade de DOCTEUR Sciences de la Vie et de la Santé Discipline: Immunologie École Doctoral: Gc2iD Présentée et soutenue publiquement par Sara Sofia de Campos Pereira Lemos Le 23 Mai 2014 CD8 T cell differentiation during immune responses Jury: Dr. Jacqueline MARVEL Rapporteur Dr. Sylvie GUERDER Rapporteur Dr. Jérôme DELON Examinateur Dr. Nicolas BLANCHARD Examinateur Dr. Benedita ROCHA Directeur de these 1 To a wonderful person, an extraordinary woman and an amazing mother... my mother, Arlete Pereira “The first precept was never to accept a thing as true until I knew it as such without a single doubt.” René Descartes (French philosopher and scientist) “We live where no one knows the answer and the struggle is to figure out the question” Joshua Schimel (in “Writing Science” book).
    [Show full text]
  • Cytotoxic CD8+ T Cells in Cancer and Cancer Immunotherapy
    www.nature.com/bjc REVIEW ARTICLE Cytotoxic CD8+ T cells in cancer and cancer immunotherapy Hans Raskov 1, Adile Orhan1,2, Jan Pravsgaard Christensen3 and Ismail Gögenur1,4 The functions of, and interactions between, the innate and adaptive immune systems are vital for anticancer immunity. Cytotoxic T cells expressing cell-surface CD8 are the most powerful effectors in the anticancer immune response and form the backbone of current successful cancer immunotherapies. Immune-checkpoint inhibitors are designed to target immune-inhibitory receptors that function to regulate the immune response, whereas adoptive cell-transfer therapies use CD8+ T cells with genetically modified receptors—chimaeric antigen receptors—to specify and enhance CD8+ T-cell functionality. New generations of cytotoxic T cells with genetically modified or synthetic receptors are being developed and evaluated in clinical trials. Furthermore, combinatory regimens might optimise treatment effects and reduce adverse events. This review summarises advances in research on the most prominent immune effectors in cancer and cancer immunotherapy, cytotoxic T cells, and discusses possible implications for future cancer treatment. British Journal of Cancer (2021) 124:359–367; https://doi.org/10.1038/s41416-020-01048-4 BACKGROUND CD8+ T CELLS The natural immune response relies on the interaction of adaptive T lymphocytes effectively navigate and scan almost all parts of the and innate immunity systems and the synergy between them. The body for unwanted or foreign material; accordingly, naive and essential aspects of this response in terms of anticancer immunity effector T cells are highly skilled migrators central to immune are the surveillance, detection and destruction of neoplastic cells.
    [Show full text]